570P A first-in-human phase I study of the AXL inhibitor DS-1205c in combination with gefitinib in subjects with EGFR-mutant NSCLC

Saved in:
Bibliographic Details
Published inAnnals of Oncology Vol. 31; p. S488
Main Authors R. Toyozawa, Isamu Okamoto, G. Takayama, M. Ishigami, M. Uno, K. Goto, Makoto Nishio, E. Slosberg, Masayuki Takeda, Haruyasu Murakami, N. Crawford, T. Jimbo, H. Horinouchi, S. Nakayama, S. Ohwada
Format Journal Article
LanguageJapanese
Published Elsevier BV 01.09.2020
Online AccessGet full text
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.684

Cover